Patents Assigned to SEDIA BIOSCIENCES CORPORATION
  • Publication number: 20230417745
    Abstract: The present disclosure relates to systems and methods for assessing viral, e.g., HIV, infection duration in a subject. More specifically, the present disclosure relates to for assessing viral, e.g., HIV, infection duration in a subject using, inter alia, a reader configured to measure both the number of signal pixels and the intensities of signal pixels to generate a quantitative signal readout that is used to assess average antibody avidity of an anti-viral antibody, e.g., an anti-HIV antibody, in a sample liquid and/or viral, e.g., HIV, infection duration in a subject.
    Type: Application
    Filed: September 6, 2023
    Publication date: December 28, 2023
    Applicant: SEDIA BIOSCIENCES CORPORATION
    Inventors: Ronald W. Mink, Matthew Quinn, Vijaya K. Mokkapati
  • Patent number: 11160478
    Abstract: Specially designed collection strips and their processing. By using specially designed collection strips, having a backer and one or more absorbent pads, in conjunction with a unique processing method, the processes of analyzing biological samples such as blood, or the like, may be done efficiency with the elimination of cross contamination risk. Identification of the sample stays with the sample throughout the process as it resides on the collection strip. The strip absorbs a known volume. The sample with identification is placed directly in an elution solution, without mechanically separating the sample from its identification information. Elimination of the need for mechanical separation tends to reduce cross contamination, as well as reducing sample processing time.
    Type: Grant
    Filed: June 1, 2018
    Date of Patent: November 2, 2021
    Assignee: SEDIA BIOSCIENCES CORPORATION
    Inventors: Stephen Carl Piacentini, Ronald William Mink, Paul Robert Smith
  • Publication number: 20200355681
    Abstract: The present disclosure relates to systems and methods for assessing viral, e.g., HIV, infection duration in a subject. More specifically, the present disclosure relates to for assessing viral, e.g., HIV, infection duration in a subject using, inter alia, a reader configured to measure both the number of signal pixels and the intensities of signal pixels to generate a quantitative signal readout that is used to assess average antibody avidity of an anti-viral antibody, e.g., an anti-HIV antibody, in a sample liquid and/or viral, e.g., HIV, infection duration in a subject.
    Type: Application
    Filed: January 30, 2019
    Publication date: November 12, 2020
    Applicant: SEDIA BIOSCIENCES CORPORATION
    Inventors: Ronald W. Mink, Matthew Quinn, Vijaya K. Mokkapati
  • Publication number: 20190029581
    Abstract: Specially designed collection strips and their processing. By using specially designed collection strips, having a backer and one or more absorbent pads, in conjunction with a unique processing method, the processes of analyzing biological samples such as blood, or the like, may be done efficiency with the elimination of cross contamination risk. Identification of the sample stays with the sample throughout the process as it resides on the collection strip. The strip absorbs a known volume. The sample with identification is placed directly in an elution solution, without mechanically separating the sample from its identification information. Elimination of the need for mechanical separation tends to reduce cross contamination, as well as reducing sample processing time.
    Type: Application
    Filed: June 1, 2018
    Publication date: January 31, 2019
    Applicant: SEDIA BIOSCIENCES CORPORATION
    Inventors: Stephen Carl PIACENTINI, Ronald William MINK, Paul Robert SMITH
  • Patent number: 9986944
    Abstract: Specially designed collection strips and their processing. By using specially designed collection strips, having a backer and one or more absorbent pads, in conjunction with a unique processing method, the processes of analyzing biological samples such as blood, or the like, may be done efficiency with the elimination of cross contamination risk. Identification of the sample stays with the sample throughout the process as it resides on the collection strip. The strip absorbs a known volume. The sample with identification is placed directly in an elution solution, without mechanically separating the sample from its identification information. Elimination of the need for mechanical separation tends to reduce cross contamination, as well as reducing sample processing time.
    Type: Grant
    Filed: November 18, 2016
    Date of Patent: June 5, 2018
    Assignee: Sedia Biosciences Corporation
    Inventors: Stephen Carl Piacentini, Ronald William Mink, Paul Robert Smith
  • Publication number: 20170065215
    Abstract: Specially designed collection strips and their processing. By using specially designed collection strips, having a backer and one or more absorbent pads, in conjunction with a unique processing method, the processes of analyzing biological samples such as blood, or the like, may be done efficiency with the elimination of cross contamination risk. Identification of the sample stays with the sample throughout the process as it resides on the collection strip. The strip absorbs a known volume. The sample with identification is placed directly in an elution solution, without mechanically separating the sample from its identification information. Elimination of the need for mechanical separation tends to reduce cross contamination, as well as reducing sample processing time.
    Type: Application
    Filed: November 18, 2016
    Publication date: March 9, 2017
    Applicant: Sedia Biosciences Corporation
    Inventors: Stephen Carl Piacentini, Ronald William Mink, Paul Robert Smith
  • Publication number: 20150320347
    Abstract: Specially designed collection strips and their processing. By using specially designed collection strips, having a backer and one or more absorbent pads, in conjunction with a unique processing method, the processes of analyzing biological samples such as blood, or the like, may be done efficiency with the elimination of cross contamination risk. Identification of the sample stays with the sample throughout the process as it resides on the collection strip. The strip absorbs a known volume. The sample with identification is placed directly in an elution solution, without mechanically separating the sample from its identification information. Elimination of the need for mechanical separation tends to reduce cross contamination, as well as reducing sample processing time.
    Type: Application
    Filed: May 7, 2015
    Publication date: November 12, 2015
    Applicant: SEDIA BIOSCIENCES CORPORATION
    Inventors: Stephen Carl Piacentini, Ronald William Mink, Paul Robert Smith